Description
A SIRT1-specific inhibitor (IC50 = 15 μM); inhibits metastatic breast cancer MDA-MB 231 cell proliferation (IC50 = 512 nM), dose-dependently increasing p53 acetylation and p53-mediated apoptosis in these cells
Formal name: 4,5,6,7-tetrahydro-2-[(E)-[(2-hydroxy-1-naphthalenyl)methylene]amino]-N-(phenylmethyl)-benzo[b]thiophene-3-carboxamide
Synonyms: ILS-JGB-1741
Molecular weight: 440.6
CAS: 1256375-38-8
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Deacetylases||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Cancer|Cell Signaling|p53 Signaling||Research Area|Cancer|Transcription Factors|p53||Research Area|Epigenetics, Transcription, & Translation|Erasers|Histone Deacetylation